Catalyst Wire Dossier Catalyst Wire Dossier

SR26334

sr26334 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SR26334, covering 2014-10-13 to 2014-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects [Phase 1]

See pricing